Thyroid Hormone Levels in Patients with Head and Neck Cancer Undergoing Radiochemotherapy: A Retrospective Study

Introduction: Head and Neck Cancers (HNCs) are a common type of cancer, affecting approximately 6% of the global cancer burden. The treatment of HNC often involves Radiochemotherapy (RCT), which can have adverse effects on the thyroid gland. The present study investigates how RCT impacts thyroid fun...

Full description

Saved in:
Bibliographic Details
Main Authors: Nidhi Rohan Purandare, Meenakshi, Shilpa Jain, Neeti Patel, Sarita A Shinde
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2025-06-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/21162/74393_CE[Ra1]_F(KR)_PF1(VD_OM)_redo_PFA(IS)_PB(VD_IS)_PN(IS).pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849419207811268608
author Nidhi Rohan Purandare
Meenakshi
Shilpa Jain
Neeti Patel
Sarita A Shinde
author_facet Nidhi Rohan Purandare
Meenakshi
Shilpa Jain
Neeti Patel
Sarita A Shinde
author_sort Nidhi Rohan Purandare
collection DOAJ
description Introduction: Head and Neck Cancers (HNCs) are a common type of cancer, affecting approximately 6% of the global cancer burden. The treatment of HNC often involves Radiochemotherapy (RCT), which can have adverse effects on the thyroid gland. The present study investigates how RCT impacts thyroid function in patients with HNC. Aim: To determine the effect of RCT on Thyroid Stimulating Hormone, (TSH) triiodothyronine and thyroxine. Materials and Methods: This was a retrospective study conducted in Department of Biochemistry at Medical College and SSG hospital, Baroda, Gujarat, India. Data of patients were collected from radiology department from period of January 2016 to April 2017. Patients who were initially euthyroid were included in present study (N=59). Thyroid levels were tested by immunoassay. Mean and standard deviation were calculated and statistical analysis was done using the Analysis of Variance (ANOVA) test. Results: The mean±Standard Deviation (SD) of various thyroid function levels before and after 1, 3, and 6 months of RCT were; serum T3=1.2±0.4, 1.6±0.5, 1.3±0.6 and 0.7±0.4 ng/mL, respectively, serum T4=9±2, 11±3, 8±2 and 5±1 μg/dL respectively and serum TSH=2.4±1.5, 1.9±1.5, 4.4±1.1 and 6.9±1.7 mIU/mL respectively. Serum T3 and serum T4 increased significantly after one month (p=0.008 and 0.004) and decreased significantly after six months of treatment (p=0.0001) whereas, serum TSH increased significantly after three months (p=0.015) of treatment. Conclusion: It was concluded that treatment of HNC with RCT may affect thyroid functions. There is a tendency to develop hyperthyroidism initially after one month of RCT, but later on, Hypothyroidism (HT) develops. So, it is advisable to test the thyroid profile on regular follow-up to enable early diagnosis and treatment of any thyroid malfunction that can develop after RCT.
format Article
id doaj-art-37a94ba8a7674942a79d2dbb917cc181
institution Kabale University
issn 2249-782X
0973-709X
language English
publishDate 2025-06-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj-art-37a94ba8a7674942a79d2dbb917cc1812025-08-20T03:32:12ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2025-06-01196BC12BC1510.7860/JCDR/2025/74393.21162Thyroid Hormone Levels in Patients with Head and Neck Cancer Undergoing Radiochemotherapy: A Retrospective StudyNidhi Rohan Purandare0Meenakshi1Shilpa Jain2Neeti Patel3Sarita A Shinde4Tutor, Department of Biochemistry, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India.Tutor, Department of Biochemistry, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India.Head, Department of Biochemistry, S.S.G Hospital and Medical College, Baroda, Gujarat, India.Tutor, Department of Biochemistry, Kiran Medical College, Surat, Gujarat, India.Professor, Department of Biochemistry, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India.Introduction: Head and Neck Cancers (HNCs) are a common type of cancer, affecting approximately 6% of the global cancer burden. The treatment of HNC often involves Radiochemotherapy (RCT), which can have adverse effects on the thyroid gland. The present study investigates how RCT impacts thyroid function in patients with HNC. Aim: To determine the effect of RCT on Thyroid Stimulating Hormone, (TSH) triiodothyronine and thyroxine. Materials and Methods: This was a retrospective study conducted in Department of Biochemistry at Medical College and SSG hospital, Baroda, Gujarat, India. Data of patients were collected from radiology department from period of January 2016 to April 2017. Patients who were initially euthyroid were included in present study (N=59). Thyroid levels were tested by immunoassay. Mean and standard deviation were calculated and statistical analysis was done using the Analysis of Variance (ANOVA) test. Results: The mean±Standard Deviation (SD) of various thyroid function levels before and after 1, 3, and 6 months of RCT were; serum T3=1.2±0.4, 1.6±0.5, 1.3±0.6 and 0.7±0.4 ng/mL, respectively, serum T4=9±2, 11±3, 8±2 and 5±1 μg/dL respectively and serum TSH=2.4±1.5, 1.9±1.5, 4.4±1.1 and 6.9±1.7 mIU/mL respectively. Serum T3 and serum T4 increased significantly after one month (p=0.008 and 0.004) and decreased significantly after six months of treatment (p=0.0001) whereas, serum TSH increased significantly after three months (p=0.015) of treatment. Conclusion: It was concluded that treatment of HNC with RCT may affect thyroid functions. There is a tendency to develop hyperthyroidism initially after one month of RCT, but later on, Hypothyroidism (HT) develops. So, it is advisable to test the thyroid profile on regular follow-up to enable early diagnosis and treatment of any thyroid malfunction that can develop after RCT.https://jcdr.net/articles/PDF/21162/74393_CE[Ra1]_F(KR)_PF1(VD_OM)_redo_PFA(IS)_PB(VD_IS)_PN(IS).pdfhypothyroidismtriiodothyroninethyroid dysfunctionthyroid stimulating hormonethyroxine
spellingShingle Nidhi Rohan Purandare
Meenakshi
Shilpa Jain
Neeti Patel
Sarita A Shinde
Thyroid Hormone Levels in Patients with Head and Neck Cancer Undergoing Radiochemotherapy: A Retrospective Study
Journal of Clinical and Diagnostic Research
hypothyroidism
triiodothyronine
thyroid dysfunction
thyroid stimulating hormone
thyroxine
title Thyroid Hormone Levels in Patients with Head and Neck Cancer Undergoing Radiochemotherapy: A Retrospective Study
title_full Thyroid Hormone Levels in Patients with Head and Neck Cancer Undergoing Radiochemotherapy: A Retrospective Study
title_fullStr Thyroid Hormone Levels in Patients with Head and Neck Cancer Undergoing Radiochemotherapy: A Retrospective Study
title_full_unstemmed Thyroid Hormone Levels in Patients with Head and Neck Cancer Undergoing Radiochemotherapy: A Retrospective Study
title_short Thyroid Hormone Levels in Patients with Head and Neck Cancer Undergoing Radiochemotherapy: A Retrospective Study
title_sort thyroid hormone levels in patients with head and neck cancer undergoing radiochemotherapy a retrospective study
topic hypothyroidism
triiodothyronine
thyroid dysfunction
thyroid stimulating hormone
thyroxine
url https://jcdr.net/articles/PDF/21162/74393_CE[Ra1]_F(KR)_PF1(VD_OM)_redo_PFA(IS)_PB(VD_IS)_PN(IS).pdf
work_keys_str_mv AT nidhirohanpurandare thyroidhormonelevelsinpatientswithheadandneckcancerundergoingradiochemotherapyaretrospectivestudy
AT meenakshi thyroidhormonelevelsinpatientswithheadandneckcancerundergoingradiochemotherapyaretrospectivestudy
AT shilpajain thyroidhormonelevelsinpatientswithheadandneckcancerundergoingradiochemotherapyaretrospectivestudy
AT neetipatel thyroidhormonelevelsinpatientswithheadandneckcancerundergoingradiochemotherapyaretrospectivestudy
AT saritaashinde thyroidhormonelevelsinpatientswithheadandneckcancerundergoingradiochemotherapyaretrospectivestudy